Progress in Neurotherapeutics and Neuropsychopharmacology
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Cambridge University Press

9780511663529

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Liquid fluoxetine versus placebo for repetitive behaviors in childhood autism

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.010 ◽

2010 ◽

pp. 105-114 ◽

Cited By ~ 1

Author(s):

Eric Hollander ◽

Erika Swanson ◽

Evdokia Anagnostou ◽

Ann Phillips ◽

William Chaplin ◽

...

Keyword(s):

Repetitive Behaviors ◽

Childhood Autism

Download Full-text

Radiotherapy with concurrent and adjuvant temozolomide: a new standard of care for glioblastoma multiforme

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.005 ◽

2010 ◽

pp. 37-52 ◽

Cited By ~ 1

Author(s):

Warren P. Mason ◽

René O. Mirimanoff ◽

Roger Stupp

Keyword(s):

Glioblastoma Multiforme ◽

Standard Of Care ◽

Adjuvant Temozolomide

Download Full-text

Introduction to neurotherapeutics and neuropsychopharmacology

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.002 ◽

2010 ◽

pp. 1-12

Author(s):

Jeffrey L. Cummings

Download Full-text

Early phase trials of minocycline in amyotrophic lateral sclerosis

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.007 ◽

2010 ◽

pp. 63-78

Author(s):

Paul H. Gordon ◽

Joseph Choi ◽

Dan H. Moore ◽

Robert G. Miller

Keyword(s):

Amyotrophic Lateral Sclerosis ◽

Early Phase ◽

Early Phase Trials ◽

Lateral Sclerosis

Download Full-text

Selegiline in the treatment of negative symptoms of schizophrenia

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.012 ◽

2010 ◽

pp. 121-132 ◽

Cited By ~ 1

Author(s):

Allison Lin ◽

J. Alexander Bodkin

Keyword(s):

Negative Symptoms

Download Full-text

Efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder: results of a double-blind, six-week study, with a six-month, double-blind, continuation phase

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.014 ◽

2010 ◽

pp. 149-164 ◽

Cited By ~ 1

Author(s):

George M. Simpson ◽

Antony Loebel ◽

Lewis Warrington ◽

Ruoyong Yang

Keyword(s):

Schizoaffective Disorder ◽

Double Blind ◽

Continuation Phase

Download Full-text

Testing multiple novel mechanisms for treating schizophrenia in a single trial

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.011 ◽

2010 ◽

pp. 115-120 ◽

Cited By ~ 2

Author(s):

Herbert Y. Meltzer

Keyword(s):

Single Trial

Download Full-text

Creatine as a potential treatment for amyotrophic lateral sclerosis

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.008 ◽

2010 ◽

pp. 79-90

Author(s):

Jeremy M. Shefner

Keyword(s):

Amyotrophic Lateral Sclerosis ◽

Potential Treatment ◽

Lateral Sclerosis

Download Full-text

AVP-923 as a novel treatment for pseudobulbar affect in ALS

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.009 ◽

2010 ◽

pp. 91-104

Author(s):

Laura E. Pope

Keyword(s):

Pseudobulbar Affect ◽

Novel Treatment

Download Full-text

Rivastigmine in the treatment of dementia associated with Parkinson's disease: a randomized, double-blind, placebo-controlled study

Progress in Neurotherapeutics and Neuropsychopharmacology ◽

10.1017/cbo9780511663529.003 ◽

2010 ◽

pp. 13-26 ◽

Cited By ~ 1

Author(s):

Sibel Tekin ◽

Roger Lane

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Progress in Neurotherapeutics and NeuropsychopharmacologyLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Cambridge University Press

Liquid fluoxetine versus placebo for repetitive behaviors in childhood autism

Radiotherapy with concurrent and adjuvant temozolomide: a new standard of care for glioblastoma multiforme

Introduction to neurotherapeutics and neuropsychopharmacology

Early phase trials of minocycline in amyotrophic lateral sclerosis

Selegiline in the treatment of negative symptoms of schizophrenia

Efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder: results of a double-blind, six-week study, with a six-month, double-blind, continuation phase

Testing multiple novel mechanisms for treating schizophrenia in a single trial

Creatine as a potential treatment for amyotrophic lateral sclerosis

AVP-923 as a novel treatment for pseudobulbar affect in ALS

Rivastigmine in the treatment of dementia associated with Parkinson's disease: a randomized, double-blind, placebo-controlled study

Progress in Neurotherapeutics and Neuropsychopharmacology
Latest Publications